In Korea, the age specific rate (ASR) for cervical cancer has steadily decreased in the last 10
years (15 per 100,000 women in 1999-2002) and the overall five year survival rate for …

Cervical cancer is the fourth most commonly diagnosed cancer and the fourth leading cause
of cancer-related death in women. The 5-year survival rate ranges from 50 to 80%, and …

Cancer of the cervix is the leading cause of cancer death in women worldwide, while in the
developed world the disease accounts for 10% of all cancer deaths [1] but is higher in …

In the last decade, progress in curing advanced cervical cancer has been disappointing. No
progress has been made since data from multiple randomized clinical trials consistently …

The primary treatment options for cervical cancer are surgery and radiation for more than a
century. However, over the last 40 years chemotherapy has been building up its reputation …

As a result of five randomized clinical trials in the late 1990s, the National Cancer Institute
issued a clinical alert in 1999 establishing weekly intravenous cisplatin at 40 mg/m2 for six …

Clinical trials are critical to achieving better outcomes for patients with advanced stage or
recurrent cervical cancer. Five randomized phase 3 trials noted efficacy of adding …

Cervical cancer has a major impact on the lives of Indian women with an estimated 122, 844
new cases of cervical cancer in the year 2012. About 80% of these cases present in a locally …

The introduction of concurrent chemotherapy and radiotherapy for the definitive treatment of
cervical cancer constituted a major advance in the management of cervical cancer, resulting …

Worldwide, cervical cancer is one of the most common cancers in women [1]. About 450,000
women are diagnosed with cervical cancer each year around the world, and another …